A detailed history of Vise Technologies, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Vise Technologies, Inc. holds 19,581 shares of NVO stock, worth $2.06 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
19,581
Previous 20,233 3.22%
Holding current value
$2.06 Million
Previous $2.89 Million 19.29%
% of portfolio
0.3%
Previous 0.51%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$119.07 - $145.42 $77,633 - $94,813
-652 Reduced 3.22%
19,581 $2.33 Million
Q2 2024

Aug 01, 2024

BUY
$122.71 - $146.91 $63,686 - $76,246
519 Added 2.63%
20,233 $2.89 Million
Q1 2024

May 15, 2024

SELL
$102.11 - $135.92 $65,452 - $87,124
-641 Reduced 3.15%
19,714 $2.53 Million
Q4 2023

Feb 07, 2024

BUY
$87.78 - $105.45 $81,372 - $97,752
927 Added 4.77%
20,355 $2.11 Million
Q3 2023

Oct 31, 2023

BUY
$90.94 - $199.54 $859,837 - $1.89 Million
9,455 Added 94.81%
19,428 $1.77 Million
Q2 2023

Aug 08, 2023

BUY
$155.98 - $172.65 $86,100 - $95,302
552 Added 5.86%
9,973 $1.61 Million
Q1 2023

May 10, 2023

BUY
$132.34 - $159.14 $72,125 - $86,731
545 Added 6.14%
9,421 $1.5 Million
Q4 2022

Feb 09, 2023

BUY
$102.55 - $135.33 $104,806 - $138,307
1,022 Added 13.01%
8,876 $1.2 Million
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $43,352 - $53,203
455 Added 6.15%
7,854 $782,000
Q2 2022

Aug 15, 2022

BUY
$103.24 - $121.81 $382,917 - $451,793
3,709 Added 100.51%
7,399 $824,000
Q1 2022

Jun 08, 2022

BUY
$93.1 - $112.54 $343,539 - $415,272
3,690 New
3,690 $410,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Vise Technologies, Inc. Portfolio

Follow Vise Technologies, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vise Technologies, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vise Technologies, Inc. with notifications on news.